Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review

Delaleu J, Deshayes S, Rodrigues F, Savey L, Rivière E, Martin Silva N, Aouba A, Amselem S, Rabant M, Grateau G, Giurgea I, Georgin-Lavialle S

Rheumatology (Oxford) · 2021

Grade Bcase series and review

Key Findings

  • AA amyloidosis preceded TRAPS diagnosis in 96% of cases
  • 47% required renal replacement therapy
  • 14% mortality after median 23-month follow-up
  • Biologic treatment preserved residual renal function

Referenced in (1 disease)

ID: pmid-33715002DOI: 10.1093/rheumatology/keab252PMID: 33715002